Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories-Reference-Cited by-同舟云学术

Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories

Published:2019-06 Issue:6 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Humphries Romney M.¹²,Abbott April N.³,Hindler Janet A.⁴

Affiliation:

1. Accelerate Diagnostics, Tucson, Arizona, USA

2. University of Arizona, Department of Pathology, Tucson, Arizona, USA

3. Deaconess Medical Center, Evansville, Illinois, USA

4. Los Angeles County Department of Public Health, Los Angeles, California, USA

Abstract

The Clinical and Laboratory Standards Institute (CLSI) has revised several breakpoints since 2010 for bacteria that grow aerobically. In 2019, these revisions include changes to the ciprofloxacin and levofloxacin breakpoints for the Enterobacteriaceae and Pseudomonas aeruginosa , daptomycin breakpoints for Enterococcus spp., and ceftaroline breakpoints for Staphylococcus aureus .

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00203-19

Reference21 articles.

1. Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

2. Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed

3. Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls

4. Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance

5. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Characterization, and Biological Evaluation of Chitosan Nanoparticles Cross-Linked with Phytic Acid and Loaded with Colistin against Extensively Drug-Resistant Bacteria;Pharmaceutics;2024-08-24

2. Bacillus subtilis -derived peptides disrupt quorum sensing and biofilm assembly in multidrug-resistant Staphylococcus aureus;mSystems;2024-08-20

3. The Occurrence of Colistin Resistance in Potential Lactic Acid Bacteria of Food-Producing Animals in India;Current Microbiology;2024-08-06

4. Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections;Scientific Reports;2024-07-07

5. Artificial Intelligence-Clinical Decision Support System in Infectious Disease Control: Combatting Multidrug-Resistant Klebsiella pneumoniae with Machine Learning;Infection and Drug Resistance;2024-07